PKU HealthCare Corp.,Ltd. researches, develops, manufactures, and sells pharmaceutical products in China. It offers products in various categories, including anti-tumor, psychoneurological, cardiovascular, immunosuppressive, antimicrobial, antipyretic and analgesic, digestive system, regulate immunity, oncology, anti-allergic, blood sugar regulation, mental disorder, and blood volume expansion. The company was formerly known as PUK International Hospital Group Southwest Synthetic Pharmaceutical Corp., Ltd. and changed its name to PKU HealthCare Corp., Ltd. in November 2013. The company was founded in 1965 and is headquartered in Chongqing, China.
Metrics to compare | 000788 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000788PeersSector | |
---|---|---|---|---|
P/E Ratio | 29.4x | 32.3x | −0.5x | |
PEG Ratio | 0.31 | −0.16 | 0.00 | |
Price/Book | 2.6x | 3.3x | 2.6x | |
Price / LTM Sales | 2.0x | 5.2x | 3.3x | |
Upside (Analyst Target) | - | 15.3% | 43.5% | |
Fair Value Upside | Unlock | 9.3% | 6.9% | Unlock |